FDA Status Tracker
Where Every Peptide Stands With the FDA
We track the FDA's compounding categories and Federal Register actions for every peptide on PepHookup. When something changes, you'll know.
A cyclic 7-residue melanocortin receptor agonist that acts centrally to drive arousal.
A mitochondria-targeted tetrapeptide that stabilizes cardiolipin to support cellular energy.
A GLP-1 receptor agonist that slows gastric emptying and reduces appetite signaling.
A dual GIP and GLP-1 receptor agonist developed for diabetes and weight management.
A linear α-MSH analog that selectively activates MC1R to drive photoprotective pigmentation.
A stabilized 44-residue GHRH analog that stimulates endogenous growth hormone secretion.
A tripeptide-copper complex that supports skin regeneration and wound healing.
A 29-residue GHRH analog that prompts the pituitary to release endogenous growth hormone.
A tripeptide antioxidant central to cellular redox, detoxification, and immune function.Next: 2026–2027
Get notified on any change
One email per FDA action. No digests, no marketing. Unsubscribe anytime.
PepHookup tracks public FDA actions. This is not legal or medical advice. Confirm current regulatory status with your provider and pharmacy before making any treatment decisions.